INGRID BERDO: Open Payments
NPI 1790169829 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 8 payments from 7 companies in 2025. Trend: 2023 $463 · 2024 $649 · 2025 $699
Food & beverage: $699
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $129 |
| ABBVIE INC. | 1 | $125 |
| UCB, Inc. | 1 | $118 |
| Axsome Therapeutics, Inc. | 1 | $114 |
| Lundbeck LLC | 1 | $104 |
| PFIZER INC. | 2 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $46 |
Products named: INGREZZA, VRAYLAR, Nayzilam, Auvelity, REXULTI, Kerendia, VYNDAQEL.
Industry payments across MI — which companies pay providers there.
